Department of Urology, Yeungnam University College of Medicine, 317-1 Daemyung-dong, Nam-gu, Daegu, 705-035, South Korea.
Int J Colorectal Dis. 2010 May;25(5):619-24. doi: 10.1007/s00384-010-0879-8. Epub 2010 Feb 19.
This study evaluates the erectile function of male patients treated by preoperative radiotherapy followed by surgery and surgery alone for locally advanced rectal cancer.
A total of 112 men treated by total mesorectal excision with autonomic nerve preservation were included. Seventy-three patients were treated by preoperative radiotherapy followed by surgery (RTS group), and 39 were treated by surgery alone (surgery group). Patients filled out the five-item version of the international index of erectile function (IIEF-5) questionnaire at least 6 months after initial erectile function assessment. We analyzed the impact of age, surgery type, location, and size of tumor on erectile function.
Total score was decreased significantly at follow-up compared to initial assessment in both RTS and surgery group (20.31 +/- 4.39 vs. 11.52 +/- 4.83, P = 0.012; 19.86 +/- 4.61 vs. 14.07 +/- 6.37, P = 0.031, respectively). Score difference was statistically higher in RTS group compared with surgery group (P = 0.028). In terms of surgery type for RTS group, score difference was statistically higher in the patients with abdominoperineal resection (APR) compared with those with lower anterior resection (P = 0.023). In comparison of score difference according to tumor location, difference was statistically higher in the patients with lower rectal cancer compared with those with upper rectal cancer (P = 0.017).
The erectile functions of patients treated by preoperative radiotherapy followed by surgery are more affected than that of patients treated by surgery alone in locally advanced rectal cancer. Also APR and lower rectal cancer were significantly associated with erectile dysfunction in the patients treated by preoperative radiotherapy followed by surgery.
本研究评估了接受术前放疗加手术和单纯手术治疗局部进展期直肠癌的男性患者的勃起功能。
共纳入 112 例接受自主神经保留全直肠系膜切除术的男性患者。73 例患者接受术前放疗加手术(RTS 组),39 例患者单纯手术治疗(手术组)。患者在初次勃起功能评估后至少 6 个月填写国际勃起功能指数 5 项问卷(IIEF-5)。我们分析了年龄、手术类型、肿瘤位置和大小对勃起功能的影响。
RTS 组和手术组在随访时的总分均明显低于初始评估(20.31±4.39 比 11.52±4.83,P=0.012;19.86±4.61 比 14.07±6.37,P=0.031)。RTS 组的评分差异明显高于手术组(P=0.028)。就 RTS 组的手术类型而言,腹会阴切除术(APR)患者的评分差异明显高于低位前切除术(P=0.023)。按肿瘤位置比较评分差异,低位直肠癌患者的评分差异明显高于高位直肠癌患者(P=0.017)。
与单纯手术治疗相比,术前放疗加手术治疗局部进展期直肠癌患者的勃起功能受影响更大。此外,术前放疗加手术治疗的患者中,APR 和低位直肠癌与勃起功能障碍显著相关。